Improve outcomes
in kidney health

Reduce costs and improve access to care
with smartphone-powered kidney screening.

From 0% to 72% Adherence 1
The majority of at-risk Americans do not take their annual urine test. Reach the untested population and increase patient engagement by making routine testing more convenient and accessible.
Kidney Check Test Kit
Send

Kidney Check kit is designed to measure albumin, an early sign of kidney damage

Smartphone Urinalysis including app, cup, and dipstick
Test

Patients test their urine using our test kit and app, snapping a picture with their phones

Results transmitted to EMR
Review

Results are analyzed, and available immediately for the doctor to review

Smartphone-Powered Kidney Testing

Promote early detection while significantly boosting revenue and quality performance. Our kidney screening service has demonstrated significant gains for health plans by preventing progression of the disease, reducing the total cost of care, and improving risk scoring. Based on an actuarial evaluation, health plans can earn a positive ROI3 within two years by increasing test adherence and identifying CKD earlier.

Get Your Custom Report

Please fill in the form to receive a detailed cost-effectiveness analysis for your health plan, including:

  • A breakdown of your at-risk population
  • Drill-down of your potential net gains 
  • ROI calculation for your total population
  • Sensitivity analysis of your cost-savings potential
By providing this information, you consent to receive relevant content from Healthy.io. For more information, visit our Privacy Policy.
By providing this information, you consent to receive relevant content from Healthy.io. For more information, visit our Privacy Policy.

1. Validated in a rollout with Geisinger Health, among consented untested population. BMC Nephrol 20, 132 (2019). https://doi.org/10.1186/s12882-019-1324-z

2. Outcomes derived from a model performed by an external credentialed actuary. The model is based on an actuarial evaluation of medical and pharmacy claims data representing 4.9 million members managed under Medicare Advantage and 12.7 million members managed under commercial plans. Net gain and ROI is calculated assuming proper management and treatment of the disease after diagnosis.